Journal of Cystic Fibrosis 2021

5 papers
The 2021 edition of the Journal of Cystic Fibrosis included research focused on infection management, therapeutic efficacy, and patient care guidelines. Studies examined the implementation of infection prevention and control measures, identifying barriers faced by healthcare workers and families. Epidemiological research analyzed longitudinal trends and regional variations in incident infection rates across United States centers from 2010 to 2016. Clinical advancements were also a central theme, with research investigating the impact of triple therapy on intravenous antibiotic requirements through registry data and randomized trials. Diagnostic imaging techniques were explored, specifically using hyperpolarized 3He MRI to quantify regional pulmonary ventilation changes following ivacaftor treatment. Additionally, the journal published comprehensive reviews and expert recommendations regarding pregnancy in individuals with cystic fibrosis. Prolific contributors during this period included researchers such as Lisa Saiman, Marianne S. Muhlebach, and John P. Mugler.

Top Authors

AuthorPapers
Karla DiazOrdaz1

Papers

Title
568: Quantifying regional pulmonary ventilation changes pre-/postivacaftor treatment in same subject using hyperpolarized 3He MRI
Barriers implementing infection prevention and control experienced by healthcare workers, people with CF and parents
Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016
Pregnancy in cystic fibrosis: Review of the literature and expert recommendations
WS08.6 Impact of triple therapy on IVantibiotic requirements in cystic fibrosis: combining evidence from a patient Registry and randomised trials